NovoCure Limited monthly returns
NovoCure Limited has averaged 1.72% per month, positive in 48% of months. Month-by-month returns for NovoCure Limited (NVCR) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
NovoCure Limited monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -1.5% | |
| Sep 2026 | -9.6% | |
| Aug 2026 | +18.9% | |
| Jul 2026 | -2.0% | |
| Jun 2026 | -11.1% | |
| May 2026 | +12.0% | |
| Apr 2026 | +39.5% | |
| Mar 2026 | -20.3% | |
| Feb 2026 | +10.2% | |
| Jan 2026 | -4.1% | |
| Dec 2025 | +0.9% | |
| Nov 2025 | +0.0% | |
| Oct 2025 | -0.9% | |
| Sep 2025 | +4.8% | |
| Aug 2025 | +6.6% | |
| Jul 2025 | -35.0% | |
| Jun 2025 | -6.9% | |
| May 2025 | +5.3% | |
| Apr 2025 | +1.8% | |
| Mar 2025 | -6.6% | |
| Feb 2025 | -22.2% | |
| Jan 2025 | -17.7% | |
| Dec 2024 | +48.7% | |
| Nov 2024 | +32.0% | |
| Oct 2024 | -2.9% | |
| Sep 2024 | -19.6% | |
| Aug 2024 | -14.6% | |
| Jul 2024 | +32.9% | |
| Jun 2024 | -22.2% | |
| May 2024 | +79.8% | |
| Apr 2024 | -21.7% | |
| Mar 2024 | +2.1% | |
| Feb 2024 | +10.0% | |
| Jan 2024 | -6.8% | |
| Dec 2023 | +21.7% | |
| Nov 2023 | -7.7% | |
| Oct 2023 | -17.6% | |
| Sep 2023 | -26.8% | |
| Aug 2023 | -32.4% | |
| Jul 2023 | -21.3% | |
| Jun 2023 | -42.2% | |
| May 2023 | +9.0% | |
| Apr 2023 | +9.6% | |
| Mar 2023 | -21.9% | |
| Feb 2023 | -15.6% | |
| Jan 2023 | +24.3% | |
| Dec 2022 | -4.5% | |
| Nov 2022 | +8.7% | |
| Oct 2022 | -7.0% | |
| Sep 2022 | -7.5% | |
| Aug 2022 | +20.8% | |
| Jul 2022 | -2.2% | |
| Jun 2022 | -13.5% | |
| May 2022 | +5.0% | |
| Apr 2022 | -7.6% | |
| Mar 2022 | +1.2% | |
| Feb 2022 | +19.2% | |
| Jan 2022 | -8.6% | |
| Dec 2021 | -19.8% | |
| Nov 2021 | -8.7% | |
| Oct 2021 | -11.7% | |
| Sep 2021 | -13.4% | |
| Aug 2021 | -12.9% | |
| Jul 2021 | -30.6% | |
| Jun 2021 | +8.7% | |
| May 2021 | -0.0% | |
| Apr 2021 | +54.4% | |
| Mar 2021 | -11.3% | |
| Feb 2021 | -7.4% | |
| Jan 2021 | -7.0% | |
| Dec 2020 | +37.7% | |
| Nov 2020 | +2.9% | |
| Oct 2020 | +9.7% | |
| Sep 2020 | +34.5% | |
| Aug 2020 | +9.2% | |
| Jul 2020 | +27.8% | |
| Jun 2020 | -12.1% | |
| May 2020 | +2.5% | |
| Apr 2020 | -2.3% | |
| Mar 2020 | -7.4% | |
| Feb 2020 | -10.7% | |
| Jan 2020 | -3.3% | |
| Dec 2019 | -8.6% | |
| Nov 2019 | +28.7% | |
| Oct 2019 | -4.2% | |
| Sep 2019 | -17.7% | |
| Aug 2019 | +9.2% | |
| Jul 2019 | +31.6% | |
| Jun 2019 | +19.0% | |
| May 2019 | +20.5% | |
| Apr 2019 | -8.5% | |
| Mar 2019 | -10.3% | |
| Feb 2019 | +9.6% | |
| Jan 2019 | +46.4% | |
| Dec 2018 | -2.4% | |
| Nov 2018 | +3.6% | |
| Oct 2018 | -36.8% | |
| Sep 2018 | +16.3% | |
| Aug 2018 | +32.5% | |
| Jul 2018 | +8.6% | |
| Jun 2018 | -0.5% | |
| May 2018 | +15.2% | |
| Apr 2018 | +25.2% | |
| Mar 2018 | +6.1% | |
| Feb 2018 | -8.5% | |
| Jan 2018 | +11.1% | |
| Dec 2017 | +4.9% | |
| Nov 2017 | -10.9% | |
| Oct 2017 | +8.8% | |
| Sep 2017 | -3.2% | |
| Aug 2017 | -0.5% | |
| Jul 2017 | +19.1% | |
| Jun 2017 | +37.8% | |
| May 2017 | +11.1% | |
| Apr 2017 | +39.5% | |
| Mar 2017 | +6.6% | |
| Feb 2017 | +19.7% | |
| Jan 2017 | -19.1% | |
| Dec 2016 | +1.3% | |
| Nov 2016 | +28.1% |
Monthly total return (since Nov 2021)#
NovoCure Limited returns by calendar month#
Every month of every year since 2016, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -1.50% — 4th of 11 Octobers since 2016 at the last close; the average October returned -9.2%.
| Month | −80%0+80% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -2.6% | -6.8% | 27% | +46.4% 2019 | -44.2% 2016 | |
| Feb | -0.2% | -6.3% | 45% | +19.7% 2017 | -22.2% 2025 | |
| Mar | -3.5% | -6.6% | 45% | +23.9% 2016 | -21.9% 2023 | |
| Apr | +10.8% | +1.8% | 55% | +54.4% 2021 | -21.7% 2024 | |
| May | +13.3% | +9.0% | 82% | +79.8% 2024 | -13.7% 2016 | |
| Jun | -3.4% | -6.9% | 36% | +37.8% 2017 | -42.2% 2023 | |
| Jul | -0.6% | -2.0% | 45% | +32.9% 2024 | -35.6% 2016 | |
| Aug | +3.5% | +6.6% | 64% | +32.5% 2018 | -32.4% 2023 | |
| Sep | -2.8% | -7.5% | 36% | +34.5% 2020 | -26.8% 2023 | |
| Oct | -9.2% | -5.6% | 20% | +9.7% 2020 | -36.8% 2018 | |
| Nov | +7.7% | +3.2% | 60% | +32.0% 2024 | -10.9% 2017 | |
| Dec | +8.0% | +1.1% | 60% | +48.7% 2024 | -19.8% 2021 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from NVCR's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is NovoCure Limited's average monthly return?
- NovoCure Limited (NVCR) has averaged about 1.72% per month, positive in roughly 48% of months. The best month was May 2024 (+79.8%) and the worst was Jan 2016 (-44.2%).
